SPIKEVAX 0.20 MG/ML DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)
Conditional Registration of SPIKEVAX 0.20 mg/mL dispersion for injection COVID-19 mRNA vaccine (nucleoside modified).
Summary of Product Characteristics
Summary of Product Characteristics
Contact Moderna